The results were presented at the annual European Academy of Dermatology and Venereology Congress.

The results were presented at the annual European Academy of Dermatology and Venereology Congress, in Lisbon, Portugal. In a single study, 81 percent of patients receiving AIN457 150mg subcutaneously monthly experienced at least a 75 percent improvement of psoriasis signs and symptoms as measured by PASI vs 9 percent for placebo at week 12 (p.. AIN457 provided quick and significant relief of symptoms in up to 81 percent of patients with psoriasis Novartis has announced excellent results from three Stage II trials showing that AIN457 produced an instant and significant improvement of symptoms in patients with moderate-to-severe plaque psoriasis.ADI has made related antibody kits for dog and pig to determine if the animals from Ebola endemic regions possess any circulating Ebola virus proteins antibodies and, therefore, exposed to Ebola virus. The antibody ELISA packages are highly delicate and need only a tiny drop of bloodstream or serum to carry out the test within two hours. The United States, United Kingdom, and Canada have started clinical trials on the most promising candidates for Ebola vaccines.